OPK
Opko Health Inc.
Nasdaq · usd
Opko Health Inc. (OPK) trades at $1.62 (+0.00%) as of 4:33:22 PM EST on Nov 17, 2026, +0.62% over the past month. Market cap is $1.2B, with 9.2 days to cover in short interest.
Stock performance
How Opko Health Inc. (OPK) stock has performed from one day to one year, with its 52-week range.
- 1D
- +0.00%
- 1W
- -5.26%
- 1M
- +0.62%
- YTD
- +28.57%
- 1Y
- +26.56%
- 52-wk range
- $0.98 – $1.86
Key statistics
Today's trading snapshot for OPK: day range, open, previous close, volume and market cap.
- Day range
- $1.59 – $1.65
- Open
- $1.60
- Prev close
- $1.62
- Volume
- 3.03M
- Market cap
- $1.2B
- Shares out
- 742.51M
Valuation and profitability ratios: P/E, P/S, ROE
Valuation and profitability ratios for Opko Health Inc.: P/E, P/S, P/B, ROE and more.
- P/E
- —
- P/S
- 2.40
- P/B
- 1.08
- P/FCF
- —
- ROE
- -13.3%
- ROA
- -7.9%
- Debt/Equity
- 0.43
- Div yield
- 0.00%
As of Nov 16, 2026
8-K filings
Material corporate events Opko Health Inc. has disclosed to the SEC on Form 8-K.
- Quarterly earningsNov 4, 2026
On November 4, 2026, OPKO Health, Inc. (the "Company") issued a press release announcing operating and financial highlights for the quarter ended September 30, 2026.
- Divestiture agreementOct 15, 2026
On October 14, 2026, OPKO Health, Inc., its wholly owned subsidiary, BioReference Health, LLC, and Laboratory Corporation of America Holdings entered into an Asset Purchase Agreement. Pursuant to the Purchase Agreement, Seller has agreed to sell and assign to Buyer certain assets of BioReference's clinical and anatomic pathology laboratory testing business, together with certain liabilities related to the Business.
- Guarantee or letter of creditAug 14, 2026
its wholly-owned subsidiaries OPKO Biologics Ltd. ("OBL") and EirGen Pharma Limited ("EirGen") as guarantors (OBL and EirGen collectively, the "Guarantors")... The Guarantors have guaranteed the obligations under the Notes and have granted a security interest in certain assets of the Guarantors.
- Director appointmentMar 19, 2026
On March 18, 2026, the Board of Directors of OPKO Health, Inc. (the "Company"), appointed Subbarao V. Uppaluri, Ph.D. as a new director with immediate effect to serve until the Company's 2026 Annual Meeting of Stockholders and until his successor shall be duly elected or appointed or his earlier death or resignation. Dr. Uppaluri is expected to be appointed to the Compensation Committee of the Board. The Board has determined that Dr. Uppaluri is independent under the applicable rules of the Securities and Exchange Commission and the Nasdaq Stock Market.
- Divestiture agreementSep 15, 2025
On March 10, 2025, OPKO, its wholly owned subsidiary, BioReference Health, LLC ('BioReference' and, together with OPKO, 'Seller'), and Laboratory Corporation of America Holdings, a Delaware corporation ('Buyer'), entered into an Asset Purchase Agreement (the 'Purchase Agreement'), pursuant to which Seller agreed to sell and assign to Buyer certain assets and liabilities of BioReference's laboratory testing businesses focused on oncology and oncology-related clinical testing services across the United States, in exchange for an aggregate purchase price of up to $225,000,000 in cash.
OPK short interest
How heavily OPK is shorted: shares short, days to cover and average daily volume.
- Days to cover
- 9.2
- Short interest
- 32.85M
- Avg volume
- 3.56M
As of · reported to FINRA twice monthly.
OPK news
The latest news and headlines about Opko Health Inc. (OPK).
- Cocrystal Pharma Provides Business Update and Reports Third Quarter 2026 Financial ResultspositiveGlobeNewswire Inc.· Nov 15, 2026
- Hims & Hers Q3 Earnings Miss Estimates, Gross Margin DownnegativeZacks Investment Research· Nov 11, 2026
- Rigetti Q3 Earnings In Line With Estimates, Revenues Down Y/YnegativeZacks Investment Research· Nov 11, 2026
- Reasons to Hold Veeva Systems Stock in Your Portfolio for NowneutralZacks Investment Research· Nov 10, 2026
- BDX Stock Down in Pre-Market Despite Q4 Earnings & Revenue BeatneutralZacks Investment Research· Nov 5, 2026
Frequently asked questions
What is the Opko Health Inc. (OPK) stock price today?
Opko Health Inc. (OPK) is trading at $1.62 (+0.00% on the day) as of 4:33:22 PM EST on Nov 17, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.
What is Opko Health Inc.?
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics.
What is the short interest in OPK?
As of Oct 30, 2026, OPK has 32.85M shares short and 9.2 days to cover.
What exchange is OPK listed on?
Opko Health Inc. (OPK) trades on Nasdaq in USD, in the PHARMACEUTICAL PREPARATIONS industry.
Build with AI
Build an analysis of OPK with your agent
Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.
Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a OPK analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.